Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norberto Corral

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Statistical Methods in Medical Research|May 17, 2018
Efficient nonparametric confidence bands for receiver operating-characteristic curvesPablo Martínez-Camblor, Sonia Pérez-Fernández, Norberto Corral
Statistical Methods in Medical Research|July 3, 2014
Receiver operating characteristic curve generalization for non-monotone relationshipsPablo Martínez-Camblor, Norberto Corral, Corsino Rey, et al.
Investigational New Drugs|August 31, 2002
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancerEmilio Esteban, Joaquín Fra, Marian Sala, et al.
Investigational New Drugs|May 11, 2002
Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancerEmilio Esteban, Joaquin Fra, Norberto Corral, et al.
Breast Cancer Research and Treatment|September 25, 2003
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding studyEmilio Esteban, Antonio Modollel, Luis González de Sande, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de AsturiasCarolina Muriel, Emilio Esteban, Norberto Corral, et al.
Investigational New Drugs|August 13, 2005
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II studyEmilio Esteban, Joaquin Fra, Yolanda Fernández, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized studyEmilio Esteban, Jose-Luis de Sande, Noemi Villanueva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Statistical Methods in Medical Research|May 17, 2018
Efficient nonparametric confidence bands for receiver operating-characteristic curvesPablo Martínez-Camblor, Sonia Pérez-Fernández, Norberto Corral
Statistical Methods in Medical Research|July 3, 2014
Receiver operating characteristic curve generalization for non-monotone relationshipsPablo Martínez-Camblor, Norberto Corral, Corsino Rey, et al.
Investigational New Drugs|August 31, 2002
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancerEmilio Esteban, Joaquín Fra, Marian Sala, et al.
Investigational New Drugs|May 11, 2002
Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancerEmilio Esteban, Joaquin Fra, Norberto Corral, et al.
Breast Cancer Research and Treatment|September 25, 2003
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding studyEmilio Esteban, Antonio Modollel, Luis González de Sande, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de AsturiasCarolina Muriel, Emilio Esteban, Norberto Corral, et al.
Investigational New Drugs|August 13, 2005
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II studyEmilio Esteban, Joaquin Fra, Yolanda Fernández, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized studyEmilio Esteban, Jose-Luis de Sande, Noemi Villanueva, et al.
Pageof 1